KCM
GOSS icon

Kalehua Capital Management’s Gossamer Bio GOSS Stock Holding History

Kalehua Capital Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.84M Buy
11,149,363
+913,070
+9% +$255K 1.05% 22
2026
Q1 		$3.36M Buy
+10,236,293
New +$16.1M 2.38% 16

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Kalehua Capital Management's GOSS Position: Q2 2026 in Review

Kalehua Capital Management increased its Gossamer Bio (GOSS) stake by 8.9% in Q2 2026, buying an estimated $255K and bringing the position to 11,149,363 shares worth $1.84M. The position accounts for 1.05% of the portfolio, ranked #22.

Kalehua Capital Management first reported a position in GOSS in Q1 2026 and has held it in 2 quarters since. The position peaked at $3.36M in Q1 2026. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Kalehua Capital Management held 11,149,363 shares of Gossamer Bio worth $1.84M as of Q2 2026.
  • Kalehua Capital Management bought 913,070 Gossamer Bio shares in Q2 2026, an estimated $255K.
  • Gossamer Bio made up 1.05% of Kalehua Capital Management's portfolio in Q2 2026, its #22 holding.
  • Kalehua Capital Management first reported a position in Gossamer Bio in Q1 2026 and has held it in 2 quarters since.
  • Kalehua Capital Management's Gossamer Bio position peaked at $3.36M in Q1 2026.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Kalehua Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.